메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Levels of soluble interleukin-2 receptor alpha (sIL-2Ra) are known to increase in the sera of patients with certain malignancies, including malignant lymphoma. This study aimed to assess the clinical significance of the sIL-2Ra level in non-Hodgkin’s lymphoma (NHL). We used ELISA to measure the sIL-2Ra levels in 48 newly diagnosed and untreated patients with NHL and evaluated the correlation between the sIL-2Ra levels and clinical characteristics and the International Prognostic Index (IPI). We monitored serum sIL-2Ra in 7 patients to compare the changes in their clinical progress with these levels. High levels of serum sIL-2Ra (≥2,000 U/mL) correlated well with parameters defining the high risk group according to the IPI, i.e., high tumor burden at diagnosis (stage III+IV) and lactate dehydrogenase ≥472 U/L. The levels were also associated with B symptoms, bone marrow involvement, and poor response to therapy. The sIL-2Ra level decreased during complete remission and was elevated during disease progression or relapse. A high level of sIL-2Ra was significantly associated with a low survival rate. These results suggest that serum sIL-2Ra might be useful as a biomarker for evaluating the prognosis of patients with NHL at the time of diagnosis and during therapy. A well-controlled, large-scale study is needed to clarify the clinical significance of sIL-2Ra in specific groups of NHL. (Korean J Lab Med 2010;30:600-5)

목차

등록된 정보가 없습니다.

참고문헌 (17)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0